Lori Minasian
Deputy Director for the Division of Cancer Prevention, National Cancer Institute, NIH, Bethesda, MD, USA
Dr. Lori Minasian, a medical oncologist, is the Deputy Director for the Division of Cancer Prevention at the US National Cancer Institute (NCI). She is a leader in the NCI clinical trials enterprise and has fostered the incorporation of patient reported outcomes (PRO) in cancer clinical trials. Dr. Minasian is one of the senior leaders in the development of the NCI’s PRO version of the CTCAE. She initiated an NCI funded consortium to develop new methods for analyzing PRO to better define patient tolerability in cancer clinical trials. In addition, she has participated in the NCI’s Women’s Malignancy Clinic seeing patients. Dr. Minasian earned a Medical Degree from the George Washington University School of Medicine in Washington, D.C. She completed a fellowship in Medical Oncology at the Memorial Sloan-Kettering Cancer Center.